• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚临床型功能性垂体腺瘤:沉默的肿瘤。

Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

机构信息

Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

出版信息

Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):447-60. doi: 10.1016/j.beem.2012.01.002. Epub 2012 May 22.

DOI:10.1016/j.beem.2012.01.002
PMID:22863387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3412996/
Abstract

Pituitary adenomas are classified by function as defined by clinical symptoms and signs of hormone hypersecretion with subsequent confirmation on immunohistochemical staining. However, positive immunostaining for pituitary cell types has been shown for clinically nonfunctioning adenomas, and this entity is classified as silent functioning adenoma. Most common in these subtypes include silent gonadotroph adenomas, silent corticotroph adenomas and silent somatotroph adenomas. Less commonly, silent prolactinomas and thyrotrophinomas are encountered. Appropriate classification of these adenomas may affect follow-up care after surgical resection. Some silent adenomas such as silent corticotroph adenomas follow a more aggressive course, necessitating closer surveillance. Furthermore, knowledge of the immunostaining characteristics of silent adenomas may determine postoperative medical therapy. This article reviews the incidence, clinical behavior, and pathologic features of clinically silent pituitary adenomas.

摘要

垂体腺瘤根据功能分类,由激素分泌过多的临床症状和体征定义,并随后通过免疫组织化学染色确认。然而,已经证明临床上无功能的腺瘤存在垂体细胞类型的阳性免疫染色,这种肿瘤被归类为无功能性腺瘤。这些亚型中最常见的包括无功能促性腺腺瘤、无功能促肾上腺皮质激素腺瘤和无功能生长激素腺瘤。不太常见的是,无功能泌乳素腺瘤和促甲状腺素腺瘤也会遇到。对这些腺瘤进行适当的分类可能会影响手术后的随访护理。一些无功能性腺瘤,如无功能促肾上腺皮质激素腺瘤,具有更具侵袭性的病程,需要更密切的监测。此外,对无功能性腺瘤的免疫染色特征的了解可能会决定术后的药物治疗。本文回顾了临床上无功能性垂体腺瘤的发病率、临床行为和病理特征。

相似文献

1
Subclinical hyperfunctioning pituitary adenomas: the silent tumors.亚临床型功能性垂体腺瘤:沉默的肿瘤。
Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):447-60. doi: 10.1016/j.beem.2012.01.002. Epub 2012 May 22.
2
Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.无功能垂体腺瘤复发及其与性别、大小和激素免疫组化特征的关系。
World Neurosurg. 2018 Dec;120:e241-e246. doi: 10.1016/j.wneu.2018.08.043. Epub 2018 Aug 20.
3
Nonfunctioning Pituitary Lesions.无功能垂体病变。
Otolaryngol Clin North Am. 2022 Apr;55(2):343-350. doi: 10.1016/j.otc.2021.12.015.
4
Rab3B immunoexpression in human pituitary adenomas.Rab3B在人垂体腺瘤中的免疫表达。
Appl Immunohistochem Mol Morphol. 2009 May;17(3):185-8. doi: 10.1097/PAI.0b013e31818fa0ed.
5
Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging.近红外成像可实时观察到垂体腺瘤经蝶窦内镜手术中叶酸受体的过度表达。
J Neurosurg. 2018 Aug;129(2):390-403. doi: 10.3171/2017.2.JNS163191. Epub 2017 Aug 25.
6
Gonadotroph adenoma with secondary hypersecretion of testosterone.促性腺激素腺瘤伴睾丸酮的继发性分泌过多。
World Neurosurg. 2013 Dec;80(6):900.e7-11. doi: 10.1016/j.wneu.2012.11.069. Epub 2012 Nov 28.
7
Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.无功能性促肾上腺皮质激素腺瘤:临床和细胞特征及长期预后。
Horm Cancer. 2010 Apr;1(2):80-92. doi: 10.1007/s12672-010-0014-x.
8
Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas.各种临床无功能性垂体腺瘤病理类型中多巴胺 2 受体的表达。
Pituitary. 2012 Jun;15(2):222-6. doi: 10.1007/s11102-011-0316-1.
9
Clinically non-functioning human pituitary adenomas.临床无功能垂体腺瘤
Can J Neurol Sci. 1992 May;19(2):228-35.
10
Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.细胞周期抑制剂p27Kip1在正常促肾上腺皮质激素细胞、促肾上腺皮质激素肿瘤及恶性垂体肿瘤中低表达。
J Clin Endocrinol Metab. 1999 Oct;84(10):3823-30. doi: 10.1210/jcem.84.10.6066.

引用本文的文献

1
Successful Multimodal Management of an Aggressive Functional Gonadotropic Pituitary Macroadenoma.侵袭性促性腺激素垂体大腺瘤的成功多模式管理
AACE Clin Case Rep. 2024 Sep 12;11(1):14-17. doi: 10.1016/j.aace.2024.09.003. eCollection 2025 Jan-Feb.
2
Somatic USP8 alteration affects the immune landscape of corticotroph pituitary adenomas- a pilot study.USP8 基因体细胞改变影响促肾上腺皮质激素垂体腺瘤的免疫图谱:一项初步研究。
Hormones (Athens). 2024 Dec;23(4):717-725. doi: 10.1007/s42000-024-00569-4. Epub 2024 May 31.
3
Elevated risk of recurrence and retreatment for silent pituitary adenomas.垂体腺瘤患者复发和再治疗风险增加。
Pituitary. 2024 Apr;27(2):204-212. doi: 10.1007/s11102-024-01382-3. Epub 2024 Feb 12.
4
Aggressive nonfunctioning pituitary neuroendocrine tumors.侵袭性无功能性垂体神经内分泌肿瘤。
Brain Tumor Pathol. 2022 Oct;39(4):183-199. doi: 10.1007/s10014-022-00441-6. Epub 2022 Jun 20.
5
Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours.无功能垂体神经内分泌肿瘤亚组中 E-和 N-钙黏蛋白的分布。
Endocrine. 2022 Jun;77(1):151-159. doi: 10.1007/s12020-022-03051-6. Epub 2022 Jun 8.
6
Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature.沉默型促肾上腺皮质激素细胞和生长激素细胞双垂体腺瘤:一例报告并文献复习
J Neurol Surg Rep. 2022 May 27;83(2):e33-e38. doi: 10.1055/s-0042-1749389. eCollection 2022 Apr.
7
Metastatic Colon Cancer in the Pituitary: A Case Report with Review of Literature.垂体转移性结肠癌:一例报告并文献复习
Asian J Neurosurg. 2021 Dec 18;16(4):872-875. doi: 10.4103/ajns.AJNS_52_21. eCollection 2021 Oct-Dec.
8
Plurihormonal pituitary macroadenoma:  a case report.多激素垂体大腺瘤:一例报告。
J Med Case Rep. 2021 Jul 29;15(1):407. doi: 10.1186/s13256-021-02948-6.
9
The silent variants of pituitary tumors: demographic, radiological and molecular characteristics.垂体瘤的静默型变体:人口统计学、影像学和分子特征。
J Endocrinol Invest. 2021 Aug;44(8):1637-1648. doi: 10.1007/s40618-020-01468-2. Epub 2021 Jan 21.
10
Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas.功能性和静默性促肾上腺皮质激素垂体腺瘤中内质网蛋白加工和细胞外基质蛋白的独特模式
Cancers (Basel). 2020 Oct 14;12(10):2980. doi: 10.3390/cancers12102980.

本文引用的文献

1
Clinically silent somatotroph adenomas are common.临床上无功能的生长激素腺瘤很常见。
Eur J Endocrinol. 2011 Jul;165(1):39-44. doi: 10.1530/EJE-11-0216. Epub 2011 Apr 14.
2
Pituitary incidentaloma: an endocrine society clinical practice guideline.垂体意外瘤:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2011 Apr;96(4):894-904. doi: 10.1210/jc.2010-1048.
3
Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients.鞍区和鞍旁肿块的垂体磁共振成像:2598 例患者 10 年经验。
J Clin Endocrinol Metab. 2011 Jun;96(6):1633-41. doi: 10.1210/jc.2011-0168. Epub 2011 Apr 6.
4
Pathogenesis of pituitary tumors.垂体肿瘤的发病机制。
Nat Rev Endocrinol. 2011 May;7(5):257-66. doi: 10.1038/nrendo.2011.40. Epub 2011 Mar 22.
5
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.高泌乳素血症的诊断和治疗:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2011 Feb;96(2):273-88. doi: 10.1210/jc.2010-1692.
6
Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.无功能性促肾上腺皮质激素腺瘤:临床和细胞特征及长期预后。
Horm Cancer. 2010 Apr;1(2):80-92. doi: 10.1007/s12672-010-0014-x.
7
Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.无库欣病(静默促肾上腺皮质激素腺瘤)和库欣病的垂体 ACTH 腺瘤的临床、激素和分子特征。
Eur J Endocrinol. 2010 Jul;163(1):35-43. doi: 10.1530/EJE-10-0076. Epub 2010 Apr 12.
8
Non-functioning pituitary adenomas.无功能垂体腺瘤。
Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):625-38. doi: 10.1016/j.beem.2009.05.005.
9
Acromegaly pathogenesis and treatment.肢端肥大症的发病机制与治疗
J Clin Invest. 2009 Nov;119(11):3189-202. doi: 10.1172/JCI39375. Epub 2009 Nov 2.
10
Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas.促甲状腺激素(TSH)分泌性腺瘤的临床病理特征:特别关注 TSH 免疫反应阳性但临床上无功能的腺瘤。
Endocr Pathol. 2009 Winter;20(4):209-20. doi: 10.1007/s12022-009-9094-y.